JP2010511665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511665A5 JP2010511665A5 JP2009539730A JP2009539730A JP2010511665A5 JP 2010511665 A5 JP2010511665 A5 JP 2010511665A5 JP 2009539730 A JP2009539730 A JP 2009539730A JP 2009539730 A JP2009539730 A JP 2009539730A JP 2010511665 A5 JP2010511665 A5 JP 2010511665A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- rabies virus
- antibody
- temperature
- chain seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87289206P | 2006-12-05 | 2006-12-05 | |
| EP06125400.9 | 2006-12-05 | ||
| EP06125400 | 2006-12-05 | ||
| US60/872,892 | 2006-12-05 | ||
| PCT/EP2007/063244 WO2008068246A1 (en) | 2006-12-05 | 2007-12-04 | Liquid anti-rabies antibody formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010511665A JP2010511665A (ja) | 2010-04-15 |
| JP2010511665A5 true JP2010511665A5 (enExample) | 2011-01-20 |
| JP5410985B2 JP5410985B2 (ja) | 2014-02-05 |
Family
ID=39092188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539730A Expired - Fee Related JP5410985B2 (ja) | 2006-12-05 | 2007-12-04 | 液体抗狂犬病抗体製剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7959922B2 (enExample) |
| EP (1) | EP2088997B1 (enExample) |
| JP (1) | JP5410985B2 (enExample) |
| KR (1) | KR101522036B1 (enExample) |
| CN (1) | CN101557799B (enExample) |
| AU (1) | AU2007328960B2 (enExample) |
| CA (1) | CA2668947C (enExample) |
| CU (1) | CU23795A3 (enExample) |
| EA (1) | EA017549B1 (enExample) |
| IL (1) | IL199004A (enExample) |
| MX (1) | MX2009005414A (enExample) |
| WO (1) | WO2008068246A1 (enExample) |
| ZA (1) | ZA200902772B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ543635A (en) | 2003-06-25 | 2008-05-30 | Crucell Holland Bv | Human C-type lectin: a suitable target molecule for binding molecules, particularly immunoconjugates, in the diagnosis, prevention and/or treatment of myeloid neoplastic diseases such as AML and CML |
| PL2314621T3 (pl) * | 2004-05-27 | 2014-08-29 | Crucell Holland Bv | Cząsteczki wiążące zdolne do neutralizowania wirusa wścieklizny i ich zastosowania |
| DK2027155T3 (en) * | 2006-06-06 | 2016-05-09 | Crucell Holland Bv | HUMAN BINDING MOLECULES with killer activity against staphylococci and uses thereof |
| WO2008068246A1 (en) | 2006-12-05 | 2008-06-12 | Crucell Holland B.V. | Liquid anti-rabies antibody formulations |
| JP2010085126A (ja) * | 2008-09-29 | 2010-04-15 | Adtec Kk | 狂犬病ウイルス中和抗体価判定具および狂犬病ウイルス中和抗体価の測定方法 |
| WO2011028961A2 (en) | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
| BR112014009866A2 (pt) | 2011-10-25 | 2018-09-04 | Onclave Therapeutics Limited | formulações de anticorpos e métodos |
| CA2866128C (en) | 2012-03-07 | 2017-02-28 | Eli Lilly And Company | Il-17 antibody formulation |
| UA117466C2 (uk) | 2012-12-13 | 2018-08-10 | Мерк Шарп Енд Доме Корп. | СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19 |
| KR20140119396A (ko) | 2013-03-29 | 2014-10-10 | 삼성전자주식회사 | 단백질 약물의 액상 제형 |
| JOP20190260A1 (ar) | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
| CN110913906A (zh) | 2017-05-02 | 2020-03-24 | 默沙东公司 | 抗lag3抗体的制剂和抗lag3抗体与抗pd-1抗体的共制剂 |
| JP7159642B2 (ja) * | 2018-06-26 | 2022-10-25 | 東ソー株式会社 | カラムの抗体に対する保持力の測定方法 |
| MX2021004356A (es) | 2018-10-18 | 2021-05-31 | Merck Sharp & Dohme Llc | Formulaciones de anticuerpos anti-rsv y metodos de uso de las mismas. |
| MA54089A (fr) | 2018-10-31 | 2022-02-09 | Merck Sharp & Dohme | Anticorps anti-pd-1 humain et procédés d'utilisation associés |
| JP7503056B6 (ja) | 2018-11-07 | 2024-07-16 | メルク・シャープ・アンド・ドーム・エルエルシー | 抗ｌａｇ３抗体および抗ｐｄ－１抗体の共－製剤 |
| JP7895285B2 (ja) | 2020-06-12 | 2026-07-27 | ナンチン リーズ バイオラブス カンパニー，リミティド | Ｔｎｆｒ２に結合する抗体およびその用途 |
| CN114748618B (zh) * | 2022-04-02 | 2024-07-19 | 重庆智翔金泰生物制药股份有限公司 | 包含针对狂犬病病毒g蛋白的双特异性抗体的药物制剂及其制备方法 |
| CN117771365B (zh) * | 2023-12-07 | 2025-07-04 | 兰州生物制品研究所有限责任公司 | 一种抗狂犬病病毒组合单克隆抗体制剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2062364T3 (es) | 1989-06-08 | 1994-12-16 | Wistar Inst | Un metodo de preparacion de una composicion para el tratamiento despues de la exposicion de infeccion de rabia. |
| DE4006630A1 (de) | 1990-03-03 | 1991-09-12 | Behringwerke Ag | Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung |
| EP0934526B1 (en) | 1996-10-08 | 2003-01-08 | U-BISys B.V. | Methods and means for selecting peptides and proteins having specific affinity for a target |
| US20040013672A1 (en) * | 2000-05-16 | 2004-01-22 | Thomas Jefferson University | Recombinant antibodies, and compositions and methods for making and using the same |
| ATE557040T1 (de) | 2001-08-21 | 2012-05-15 | Univ Jefferson | Rekombinante antikörper sowie zusammensetzungen und verfahren zu deren herstellung und verwendung |
| NZ537277A (en) | 2002-07-18 | 2008-04-30 | Crucell Holland Bv | Recombinant production of mixtures of antibodies |
| AU2004270409A1 (en) * | 2003-09-04 | 2005-03-17 | Crucell Holland B.V. | Antigenic peptides of rabies virus and uses thereof |
| WO2005035574A1 (ja) * | 2003-10-09 | 2005-04-21 | Chugai Seiyaku Kabushiki Kaisha | IgM高濃度安定化溶液 |
| WO2005035573A1 (ja) * | 2003-10-09 | 2005-04-21 | Chugai Seiyaku Kabushiki Kaisha | タンパク質溶液の安定化方法 |
| WO2005063291A1 (ja) * | 2003-12-25 | 2005-07-14 | Kirin Beer Kabushiki Kaisha | 抗体を含有する安定な水性医薬製剤 |
| PL2314621T3 (pl) * | 2004-05-27 | 2014-08-29 | Crucell Holland Bv | Cząsteczki wiążące zdolne do neutralizowania wirusa wścieklizny i ich zastosowania |
| ES2407468T3 (es) * | 2005-04-18 | 2013-06-12 | Yeda Research And Development Company Limited | Formulaciones de anticuerpos anti-hepatitis B (HBV) estabilizadas |
| WO2008068246A1 (en) | 2006-12-05 | 2008-06-12 | Crucell Holland B.V. | Liquid anti-rabies antibody formulations |
-
2007
- 2007-12-04 WO PCT/EP2007/063244 patent/WO2008068246A1/en not_active Ceased
- 2007-12-04 EP EP07847749.4A patent/EP2088997B1/en active Active
- 2007-12-04 MX MX2009005414A patent/MX2009005414A/es active IP Right Grant
- 2007-12-04 AU AU2007328960A patent/AU2007328960B2/en not_active Ceased
- 2007-12-04 CN CN2007800448444A patent/CN101557799B/zh not_active Expired - Fee Related
- 2007-12-04 KR KR1020097013012A patent/KR101522036B1/ko not_active Expired - Fee Related
- 2007-12-04 US US12/312,967 patent/US7959922B2/en not_active Expired - Fee Related
- 2007-12-04 CA CA2668947A patent/CA2668947C/en active Active
- 2007-12-04 JP JP2009539730A patent/JP5410985B2/ja not_active Expired - Fee Related
- 2007-12-04 EA EA200970533A patent/EA017549B1/ru unknown
-
2009
- 2009-04-21 ZA ZA2009/02772A patent/ZA200902772B/en unknown
- 2009-05-27 IL IL199004A patent/IL199004A/en active IP Right Grant
- 2009-06-04 CU CU20090099A patent/CU23795A3/es not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110062620B (zh) | 液体药物组合物 | |
| EP3681483B1 (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| JP5410985B2 (ja) | 液体抗狂犬病抗体製剤 | |
| JP7695277B2 (ja) | 安定なペプチド組成物 | |
| JP2000504327A (ja) | 高度に濃縮された、凍結乾燥された、および液体の、因子▲ｉｘ▼処方 | |
| RS66182B1 (sr) | Stabilne višedozne kompozicije koje sadrže antitelo i konzervans | |
| RU2484847C2 (ru) | Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения | |
| AU6757600A (en) | Rotavirus vaccine formulations | |
| JP4871720B2 (ja) | 血清アルブミンを含まない、安定なヒトエリスロポエチン水溶液 | |
| CN107645956B (zh) | 包含阿那白滞素的组合物 | |
| JP7798791B2 (ja) | ウイルス感染症の治療のための肺サーファクタントタンパク質ｄの使用 | |
| WO2025005804A1 (en) | Mucoadhesive formulation | |
| JP2023525565A5 (enExample) | ||
| EP4734957A1 (en) | Mucoadhesive formulation | |
| JP2024543931A5 (enExample) | ||
| AU2008202660B2 (en) | Rotavirus vaccine formulations | |
| JP2023501155A5 (enExample) | ||
| JP2023553641A (ja) | 抗ｉｌ５ｒ抗体製剤 | |
| EA043419B1 (ru) | Способ получения лиофилизированного фармацевтического состава на основе терапевтического белка | |
| HK40033832B (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| CN1897929A (zh) | 包含5－甲基－2－(2′－氯－6′－氟苯胺基)苯乙酸的药物组合物 | |
| NZ739899B2 (en) | Biopharmaceutical compositions |